Market Overview

Wedbush Securities Reiterates Outperform Rating, $102 PT on Humana

Share:
Related HUM
Citi Concerned With Near-Term Risks For Cotiviti, Initiates At Neutral
12 Stocks You Should Be Watching Today
California insurance chief says Aetna-Humana merger "anti-competitive" (Seeking Alpha)

In a report published Monday, Wedbush Securities reiterated its Outperform rating and $102.00 price target on Humana (NYSE: HUM).

Wedbush Securities noted, “4Q12 EPS of $1.19 was above consensus of $1.06 driven by lower retail and group MLR. Retail MLR of 82.6% (82.8% ex $15M PPD) was below consensus of 84%, but above our 82.1%. Group MLR of 87.1% was below consensus of 88.2%, but above our 86.7%. SG&A of 17.3% was 48bps below our estimate, but 12bps above consensus. Revenue of $9.6B was $0.3B below our estimate of $9.9B, up 6% from the prior year. MA risk enrollment was 2.3M, 6.3K below our estimate of 2.3M lives and total PDP enrollment was 3M, 7.6K below our estimate. CFO of $0.2B was 1.1x net income, debt-to-cap increased 711bps to 23% and free cash at the parent is $346M, down from $522M in 3Q12 post repurchases and dividends. Humana repurchased 6.25M shares during the year for $460M. Days claims payable were 48.5 days, down 3.1 days sequentially.”

Humana closed on Friday at $75.35.

Latest Ratings for HUM

DateFirmActionFromTo
Dec 2015Credit SuisseInitiates Coverage onNeutral
Sep 2015JP MorganInitiates Coverage onOverweight
Sep 2015RBC CapitalMaintainsSector Perform

View More Analyst Ratings for HUM
View the Latest Analyst Ratings

Posted-In: Wedbush SecuritiesAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HUM)

View Comments and Join the Discussion!